212 related articles for article (PubMed ID: 19758804)
1. The use of mushroom-forming fungi for the production of N-glycosylated therapeutic proteins.
Berends E; Scholtmeijer K; Wösten HA; Bosch D; Lugones LG
Trends Microbiol; 2009 Oct; 17(10):439-43. PubMed ID: 19758804
[TBL] [Abstract][Full Text] [Related]
2. Uncorking the biomanufacturing bottleneck.
Dove A
Nat Biotechnol; 2002 Aug; 20(8):777-9. PubMed ID: 12148000
[No Abstract] [Full Text] [Related]
3. Increased production of chymosin by glycosylation.
van den Brink HJ; Petersen SG; Rahbek-Nielsen H; Hellmuth K; Harboe M
J Biotechnol; 2006 Sep; 125(2):304-10. PubMed ID: 16621086
[TBL] [Abstract][Full Text] [Related]
4. Advances in plant molecular farming.
Obembe OO; Popoola JO; Leelavathi S; Reddy SV
Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
[TBL] [Abstract][Full Text] [Related]
5. The molecular biology of production cell lines.
Simonsen CC; McGrogan M
Biologicals; 1994 Jun; 22(2):85-94. PubMed ID: 7917237
[TBL] [Abstract][Full Text] [Related]
6. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.
Gerngross TU
Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceuticals derived from genetically modified plants.
Goldstein DA; Thomas JA
QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic antibody production technologies: molecules, applications, expression and purification.
Humphreys DP; Glover DJ
Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
[TBL] [Abstract][Full Text] [Related]
9. Downstream processing of recombinant proteins from transgenic feedstock.
Nikolov ZL; Woodard SL
Curr Opin Biotechnol; 2004 Oct; 15(5):479-86. PubMed ID: 15464381
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological significance of glycosylation in therapeutic proteins.
Li H; d'Anjou M
Curr Opin Biotechnol; 2009 Dec; 20(6):678-84. PubMed ID: 19892545
[TBL] [Abstract][Full Text] [Related]
11. Challenges in therapeutic glycoprotein production.
Sethuraman N; Stadheim TA
Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceuticals in China.
Hu X; Ma Q; Zhang S
Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
[TBL] [Abstract][Full Text] [Related]
13. The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.
Akbari F; Eskandani M; Khosroushahi AY
World J Microbiol Biotechnol; 2014 Nov; 30(11):2783-96. PubMed ID: 25115849
[TBL] [Abstract][Full Text] [Related]
14. Recombinant expression systems in the pharmaceutical industry.
Schmidt FR
Appl Microbiol Biotechnol; 2004 Sep; 65(4):363-72. PubMed ID: 15480623
[TBL] [Abstract][Full Text] [Related]
15. Fermentation processes for prokaryotic cells.
Muth WL
Bioprocess Technol; 1991; 13():155-65. PubMed ID: 1367132
[No Abstract] [Full Text] [Related]
16. Plant-made pharmaceuticals: leading products and production platforms.
Paul M; Ma JK
Biotechnol Appl Biochem; 2011; 58(1):58-67. PubMed ID: 21446960
[TBL] [Abstract][Full Text] [Related]
17. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceuticals from plants: a multitude of options for posttranslational modifications.
Warzecha H
Biotechnol Genet Eng Rev; 2008; 25():315-30. PubMed ID: 21412360
[TBL] [Abstract][Full Text] [Related]
19. Mammalian cell culture systems for recombinant protein production.
Birch JR; Froud SJ
Biologicals; 1994 Jun; 22(2):127-33. PubMed ID: 7917229
[No Abstract] [Full Text] [Related]
20. [Health security--GMOs in therapeutics].
Trouvin JH
Ann Pharm Fr; 2003 Mar; 61(2):103-8. PubMed ID: 12668948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
